Ignite Creation Date:
2025-12-25 @ 1:20 AM
Ignite Modification Date:
2026-01-07 @ 3:09 PM
Study NCT ID:
NCT02682693
Status:
COMPLETED
Last Update Posted:
2021-02-02
First Post:
2016-01-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Denosumab as an add-on Neoadjuvant Treatment (GeparX)
Sponsor:
GBG Forschungs GmbH
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-02-13
Start Date Type:
ACTUAL
Primary Completion Date:
2019-12-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-12-31
Completion Date Type:
ACTUAL
First Submit Date:
2016-01-27
First Submit QC Date:
None
Study First Post Date:
2016-02-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-02-01
Last Update Post Date:
2021-02-02
Last Update Post Date Type:
ACTUAL